Adage Capital Partners Gp, L.L.C. Immunic, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Immunic, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,398,600 shares of IMUX stock, worth $993,006. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,398,600
Previous 1,398,600
-0.0%
Holding current value
$993,006
Previous $1.4 Million
9.01%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IMUX
# of Institutions
75Shares Held
40.2MCall Options Held
1.14MPut Options Held
130K-
Bvf Inc San Francisco, CA8.9MShares$6.32 Million0.43% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$5.18 Million0.66% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$3.16 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.93MShares$2.79 Million0.0% of portfolio
-
Gratus Capital LLC2.11MShares$1.5 Million0.1% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $21.7M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...